Financial Ratios

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE110.550.15 (+0.14 %)
PREV CLOSE ( ) 110.40
OPEN PRICE ( ) 110.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3104
TODAY'S LOW / HIGH ( )108.70 112.00
52 WK LOW / HIGH ( )96 227.95
NSE110.851.55 (+1.42 %)
PREV CLOSE( ) 109.30
OPEN PRICE ( ) 109.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 110.85 (76)
VOLUME 16719
TODAY'S LOW / HIGH( ) 109.05 113.80
52 WK LOW / HIGH ( )97.7 227.9
Select year
ParticularsMar2021Mar2020Mar2019Mar2018Mar2017
Operational & Financial Ratios
   Earnings Per Share (Rs)-14.45-16.04-12.03-12.97-11.68
   CEPS(Rs)-11.84-13.44-9.39-9.61-8.30
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-23.91-18.14-8.59-12.941.07
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-32.73-55.53-20.44-22.21-226.62
   EBIT Margin(%)-41.12-68.45-28.74-37.48-355.81
   Pre Tax Margin(%)-52.81-86.41-41.90-52.77-454.63
   PAT Margin (%)-52.81-86.41-41.90-52.77-454.63
   Cash Profit Margin (%)-43.27-72.41-32.68-40.48-334.70
Performance Ratios
   ROA(%)-19.36-20.91-14.92-14.38-13.46
   ROE(%)0.000.000.000.00-296.70
   ROCE(%)-44.33-56.96-35.41-28.95-27.13
   Asset Turnover(x)0.370.240.360.270.03
   Sales/Fixed Asset(x)0.210.140.210.150.02
   Working Capital/Sales(x)-2.01-1.38-2.00-1.35-0.19
Efficiency Ratios
   Fixed Capital/Sales(x)4.697.154.866.7562.29
   Receivable days1.7117.0012.3610.3483.55
   Inventory Days107.38130.8779.0792.84573.34
   Payable days305.42507.31309.62413.883558.82
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-7.50-6.09-12.36-16.49-11.65
   Price/Book(x)-3.72-4.52-13.50-12.6993.20
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)5.126.394.798.3352.43
   EV/Core EBITDA(x)-16.20-11.74-24.27-38.56-23.35
   EV/EBIT(x)-12.44-9.33-16.68-22.22-14.73
   EV/CE(x)1.731.601.612.241.52
   M Cap / Sales3.254.414.046.6838.99
Growth Ratio
   Net Sales Growth(%)60.72-30.0441.38856.86173.74
   Core EBITDA Growth(%)6.79-92.84-29.297.9430.32
   EBIT Growth(%)3.45-66.64-8.41-0.7919.39
   PAT Growth(%)1.78-44.28-12.27-11.061.66
   EPS Growth(%)9.89-33.307.22-11.066.53
Financial Stability Ratios
   Total Debt/Equity(x)-2.16-2.03-3.74-3.1632.19
   Current Ratio(x)0.440.440.560.410.41
   Quick Ratio(x)0.100.090.400.130.24
   Interest Cover(x)-3.52-3.81-2.18-2.45-3.60
   Total Debt/Mcap(x)0.580.450.280.250.35

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)